Table. Overview of camel samples and MERS-CoV RNA positivity in study of MERS-CoV incidence in nomadic dromedaries with putative transmission to humans, Kenya, 2022–2023*.
| Region | MERS-CoV RNA–positive samples/total samples (%) | Town of origin | MERS-CoV RNA–positive samples/total samples (%) |
|
|---|---|---|---|---|
| Female camels | Male camels | |||
| Isiolo | 15/859 (1.75) | Burat | 1/252 (0.4) | 10/326 (3.1) |
| Bulla Pesa | 0/2 | 0/0 | ||
| Kinna | 0/13 | 1/19 (5.3) | ||
| Oldo/Nyiro | 0/2 | 2/23 (8.7) | ||
| Garbatulla | 0/1 | 0/1 | ||
|
|
|
Ngare Mara |
0/106 |
0/114 |
| Marsabit | 26/1,846 (1.41) | Laisamis | 1/250 (0.4) | 21/1,591 (1.3) |
| Marsabit Central | 0/0 | 0/1 | ||
| Sololo | 0/1 | 0/0 | ||
| North Horr | 0/0 | 0/2 | ||
|
|
|
not defined |
0/0 |
0/1 |
| Samburu |
0/6 (0) |
Wamba East |
0/0 |
0/6 |
| Total | 36/2,711 (1.3) | 2/627 (0.3) | 34/2,084 (1.6) | |
*MERS-CoV, Middle East respiratory syndrome coronavirus.